Study suggests metformin may prevent blood cancer
April 17, 2025
A new study from the University of Cambridge suggests that metformin, a diabetes medication, may prevent acute myeloid leukemia in high-risk individuals. The research revealed that metformin inhibits the growth of cancerous cells, providing hope for disease prevention. Professor Georgios Vasileiou, who led the research, emphasizes the importance of early detection and intervention. The study's findings could lead to clinical trials for using metformin as a preventive treatment.